REPORTS

Let’s Pullulate and Expand Your Business

OTC Drug Market - Global Professional Analysis and Forecast to 2026

Nov 14, 2019  |  137 PAGES  |  REPORT CODE: CMM236752
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide OTC Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.8% during the forecast period.

This report presents the market size and development trends by detailing the OTC Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the OTC Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of OTC Drug industry and will help you to build a panoramic view of the industrial development.

OTC Drug Market, By Type:

  • Cough, Cold, and Flu Products

  • Analgesics

  • Dermatology Products

  • Gastrointestinal Products

  • Vitamins, Mineral, and Supplements (VMS)

  • Weight Loss/Dietary Products

  • Ophthalmic Products

  • Others

OTC Drug Market, By Application:

  • Hospital Pharmacy

  • Retail Pharmacy

  • Convenience Store

  • Others

Some of the leading players are as follows:

  • GlaxoSmithKline

  • Johnson and Johnson

  • Reckitt Benckiser

  • Sun Pharmaceuticals Limited

  • Piramal Enterprises

  • Abbott

  • Dabur India Limited

  • Bayer Healthcare AG

  • Cipla Limited

  • Emami Limited

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 OTC Drug Market: Technology Type Analysis

  • 4.1 OTC Drug Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 OTC Drug Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Cough, Cold, and Flu Products

    • 4.3.2 Analgesics

    • 4.3.3 Dermatology Products

    • 4.3.4 Gastrointestinal Products

    • 4.3.5 Vitamins, Mineral, and Supplements (VMS)

    • 4.3.6 Weight Loss/Dietary Products

    • 4.3.7 Ophthalmic Products

    • 4.3.8 Others

5 OTC Drug Market: Product Analysis

  • 5.1 OTC Drug Product Market Share Analysis, 2018 & 2026

  • 5.2 OTC Drug Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 OTC Drug Market: Application Analysis

  • 6.1 OTC Drug Application Market Share Analysis, 2018 & 2026

  • 6.2 OTC Drug Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital Pharmacy

    • 6.3.2 Retail Pharmacy

    • 6.3.3 Convenience Store

    • 6.3.4 Others

7 OTC Drug Market: Regional Analysis

  • 7.1 OTC Drug Regional Market Share Analysis, 2018 & 2026

  • 7.2 OTC Drug Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 GlaxoSmithKline

    • 9.1.1 GlaxoSmithKline Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Johnson and Johnson

    • 9.2.1 Johnson and Johnson Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Reckitt Benckiser

    • 9.3.1 Reckitt Benckiser Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Sun Pharmaceuticals Limited

    • 9.4.1 Sun Pharmaceuticals Limited Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Piramal Enterprises

    • 9.5.1 Piramal Enterprises Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Abbott

    • 9.6.1 Abbott Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Dabur India Limited

    • 9.7.1 Dabur India Limited Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Bayer Healthcare AG

    • 9.8.1 Bayer Healthcare AG Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Cipla Limited

    • 9.9.1 Cipla Limited Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Emami Limited

    • 9.10.1 Emami Limited Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 63 Figures and 121 Tables)

  • Figure Cough, Cold, and Flu Products OTC Drug market, 2015 - 2026 (USD Million)

  • Figure Analgesics OTC Drug market, 2015 - 2026 (USD Million)

  • Figure Dermatology Products OTC Drug market, 2015 - 2026 (USD Million)

  • Figure Gastrointestinal Products OTC Drug market, 2015 - 2026 (USD Million)

  • Figure Vitamins, Mineral, and Supplements (VMS) OTC Drug market, 2015 - 2026 (USD Million)

  • Figure Weight Loss/Dietary Products OTC Drug market, 2015 - 2026 (USD Million)

  • Figure Ophthalmic Products OTC Drug market, 2015 - 2026 (USD Million)

  • Figure Others OTC Drug market, 2015 - 2026 (USD Million)

  • Figure Hospital Pharmacy market, 2015 - 2026 (USD Million)

  • Figure Retail Pharmacy market, 2015 - 2026 (USD Million)

  • Figure Convenience Store market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America OTC Drug market, by country, 2015 - 2026 (USD Million)

  • Table North America OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table North America OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table North America OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.S. OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.S. OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Canada OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Canada OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Europe OTC Drug market, by country, 2015 - 2026 (USD Million)

  • Table Europe OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Europe OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Europe OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.K. OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.K. OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Germany OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Germany OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table France OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table France OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Italy OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Italy OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Spain OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Spain OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific OTC Drug market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table China OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table China OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Japan OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Japan OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table India OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table India OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Latin America OTC Drug market, by country, 2015 - 2026 (USD Million)

  • Table Latin America OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Latin America OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Latin America OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Brazil OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Brazil OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Mexico OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Mexico OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Argentina OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Argentina OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table MEA OTC Drug market, by country, 2015 - 2026 (USD Million)

  • Table MEA OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table MEA OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table MEA OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table South Africa OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table South Africa OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria OTC Drug market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria OTC Drug market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria OTC Drug market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson and Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Reckitt Benckiser Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sun Pharmaceuticals Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Piramal Enterprises Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dabur India Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Healthcare AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cipla Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Emami Limited Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top